Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TAK-931 in metastatic pancreatic cancer, colorectal cancer, and other advanced solid tumors has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• TAK-931 (TAK-931)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Metastatic Pancreatic Cancer, Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-09-20